Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Prophase Labs ( (PRPH) ) has provided an update.
ProPhase Labs, Inc. resolved a compliance issue with Nasdaq’s audit committee requirements after a vacancy was created by the resignation of Eleanor McBrier. The company appointed Carolina Abenante to the Board and Audit Committee, regaining compliance with Nasdaq rules as confirmed by Nasdaq on June 25, 2025.
Spark’s Take on PRPH Stock
According to Spark, TipRanks’ AI Analyst, PRPH is a Neutral.
ProPhase Labs’ overall stock score is primarily constrained by its weak financial performance, characterized by declining revenue and high leverage. While the earnings call suggests potential future improvements, current valuation metrics and mixed technical signals present ongoing challenges.
To see Spark’s full report on PRPH stock, click here.
More about Prophase Labs
Average Trading Volume: 2,713,533
Technical Sentiment Signal: Sell
Current Market Cap: $15.25M
Learn more about PRPH stock on TipRanks’ Stock Analysis page.